COUNTDOWN TO OMERACT 2027!

Day
Hour
Minute
Second
Untitled design (2)

OMERACT 2027

May 19–23, 2027 | Kingbridge Centre, Toronto, Canada

Developing Core Outcome Sets Through Collaboration

OMERACT 2027 Scientific Program: Sessions Selected

We are pleased to announce that the Special Interest Group (SIG) sessions, Workshops, and Symposium for OMERACT 2027 have been formally selected following review of Working Group applications.
The 2027 program reflects the full breadth of OMERACT activity, spanning core domain set endorsement, instrument selection, composite outcome development, imaging, and methodological innovation, with strong integration of patient engagement and equity considerations across sessions.
Workshop/Plenaries
The 2027 workshops will focus on advancing methodological rigor and practical guidance across OMERACT processes:
  • Patient Engagement
  • Equity, Diversity & Inclusivity (EDI)
  • OMERACT Methodology
These sessions are designed to produce actionable outputs, including guidance, tools, and frameworks to support Working Groups across the OMERACT pathway.

Symposium: Prevention and Risk-Stage Rheumatic Disease: Rethinking Outcomes, Core Sets, and OMERACT’s Role
This cross-cutting symposium will address a major emerging challenge in rheumatology research: how to define and measure outcomes in prevention and early disease states.
Key themes include:
  • Defining “at-risk” populations
  • Identifying appropriate endpoints beyond disease onset
  • Integrating patient-reported outcomes in prevention contexts
  • Addressing regulatory and industry considerations
As trials move earlier in the disease trajectory, this session will explore whether new or adapted core outcome frameworks are required, and what role OMERACT should play in shaping this space

Special Interest Group (SIG) Sessions

Composite Outcome Development
  • Flares in Osteoarthritis (OA)
  • Remission in Rheumatoid Arthritis (RA): Patient Perspective
Core Domain Set Development
  • Sjögren’s Disease
Imaging
  • MRI Taskforce
  • Ultrasound
Methods
  • Patient Preferences to Value Health Outcomes for RCT's
Instrument Selection
  • Behçet’s Syndrome & Large Vessel Vasculitis
  • Foot & Ankle Disorders
  • Juvenile Idiopathic Arthritis (JIA) & JIA Flare
  • Myositis
  • Pain
  • Safety
  • Scleroderma Vascular Disease
  • Shared Decision Making
  • Shoulder Disorders
  • Systemic Lupus Erythematosus (SLE)

KEY DATES

Stay on track with important milestones leading up to OMERACT 2027. Deadlines are aligned to ensure Working Groups, PRPs, and delegates have time to prepare, collaborate, and participate fully.
  • Early Bird Registration Opens Fall 2026
  • May 19–23 2027 – Conference
OMERACT 2027 Save the Date

OMERACT Conference Frequently Asked Questions

Meet the Planning Team

Philip Conaghan

Philip Conaghan

writetomayadesai@outlook.com

Maya Desai, PRP

Shawna Grosskleg

Shawna Grosskleg

cathis hofstetter

Catherine Hofstetter, PRP

Lee Simon

Lee Simon

zahi.touma@uhn.ca

Zahi Touma

Peter Tugwell

Peter Tugwell

Dr. Mark Campbell

Mark Campbell, Emerging Leader

Caroline Flurey

Caroline Flurey, Emerging Leader

New to OMERACT?

OMERACT Working Groups follow a structured, consensus-driven approach to developing Core Outcome Sets. Explore how this process unfolds and discover more about how OMERACT advances outcome measurement in rheumatology.

Scroll to Top